Literature DB >> 26366004

Placenta Accreta and Total Placenta Previa in the 19th Week of Pregnancy.

S Findeklee1, S D Costa1.   

Abstract

Placentation disorders are the result of impaired embedding of the placenta in the endometrium. The prevalence of these disorders is estimated to be around 0.3 %. A history of previous prior uterine surgery (especially cesarean section and curettage) is the most common risk factor. Impaired placentation is differentiated into deep placental attachment; marginal, partial and total placenta previa; and placenta accreta, increta and percreta. Treatment depends on the severity of presentation and ranges from expectant management to emergency hysterectomy. In most cases, preterm termination of pregnancy is necessary. We report here on the case of a 39-year-old woman with placenta accreta and total placenta previa who underwent hysterectomy in the 19th week of pregnancy.

Entities:  

Keywords:  placenta accreta; placenta previa; pregnancy

Year:  2015        PMID: 26366004      PMCID: PMC4554505          DOI: 10.1055/s-0035-1557763

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  11 in total

Review 1.  The morbidly adherent placenta: an overview of management options.

Authors:  Stergios K Doumouchtsis; Sabaratnam Arulkumaran
Journal:  Acta Obstet Gynecol Scand       Date:  2010-09       Impact factor: 3.636

Review 2.  Defective implantation and placentation: laying the blueprint for pregnancy complications.

Authors:  Errol R Norwitz
Journal:  Reprod Biomed Online       Date:  2006-10       Impact factor: 3.828

Review 3.  [Management of placenta previa and accreta].

Authors:  G Kayem; H Keita
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2014-11-06

4.  Maternal morbidity associated with multiple repeat cesarean deliveries.

Authors:  Robert M Silver; Mark B Landon; Dwight J Rouse; Kenneth J Leveno; Catherine Y Spong; Elizabeth A Thom; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary J O'Sullivan; Baha Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

5.  Clinical risk factors for placenta previa-placenta accreta.

Authors:  D A Miller; J A Chollet; T M Goodwin
Journal:  Am J Obstet Gynecol       Date:  1997-07       Impact factor: 8.661

6.  Conservative versus extirpative management in cases of placenta accreta.

Authors:  Gilles Kayem; Céline Davy; François Goffinet; Carole Thomas; Denis Clément; Dominique Cabrol
Journal:  Obstet Gynecol       Date:  2004-09       Impact factor: 7.661

7.  Medical treatment of placenta accreta with methotrexate.

Authors:  S Arulkumaran; C S Ng; I Ingemarsson; S S Ratnam
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

Review 8.  Management of placenta accreta.

Authors:  Loïc Sentilhes; François Goffinet; Gilles Kayem
Journal:  Acta Obstet Gynecol Scand       Date:  2013-10       Impact factor: 3.636

Review 9.  Conservative management of morbidly adherant placenta - a case report and review of literature.

Authors:  Muntaha Khan; P Sachdeva; R Arora; S Bhasin
Journal:  Placenta       Date:  2013-08-12       Impact factor: 3.481

10.  Prenatal sonographic diagnosis of placenta accreta--impact on maternal and neonatal outcomes.

Authors:  Tania Hall; Joseph R Wax; F Lee Lucas; Angelina Cartin; Michael Jones; Michael G Pinette
Journal:  J Clin Ultrasound       Date:  2014-06-27       Impact factor: 0.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.